News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
864,632 Results
Type
Article (87613)
Company Profile (823)
Press Release (776179)
Multimedia
Podcasts (181)
Webinars (28)
Section
Business (233138)
Career Advice (4140)
Deals (39823)
Drug Delivery (141)
Drug Development (91308)
Employer Resources (203)
FDA (18312)
Job Trends (17411)
News (397568)
Policy (39934)
Tag
Academia (3005)
Academic (2)
Accelerated approval (19)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (151)
Alzheimer's disease (1704)
Antibody-drug conjugate (ADC) (281)
Approvals (18366)
Artificial intelligence (543)
Autoimmune disease (118)
Automation (31)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (174)
Biotechnology (487)
Bladder cancer (141)
Brain cancer (54)
Breast cancer (542)
Cancer (4326)
Cardiovascular disease (384)
Career advice (3562)
Career pathing (38)
CAR-T (263)
CDC (57)
Cell therapy (727)
Cervical cancer (33)
Clinical research (76073)
Collaboration (1493)
Company closure (4)
Compensation (1000)
Complete response letters (64)
COVID-19 (2967)
CRISPR (92)
C-suite (660)
Cystic fibrosis (144)
Data (5265)
Decentralized trials (2)
Denatured (66)
Depression (123)
Diabetes (477)
Diagnostics (7127)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (253)
Drug pricing (198)
Drug shortages (36)
Duchenne muscular dystrophy (213)
Earnings (99795)
Editorial (57)
Employer branding (25)
Employer resources (173)
Events (133870)
Executive appointments (1003)
FDA (20980)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (20)
Funding (1344)
Gene editing (192)
Generative AI (53)
Gene therapy (588)
GLP-1 (1055)
Government (5401)
Grass and pollen (8)
Guidances (376)
Healthcare (20941)
HIV (52)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (268)
Immuno-oncology (24)
Indications (62)
Infectious disease (3226)
Inflammatory bowel disease (196)
Inflation Reduction Act (16)
Influenza (106)
Intellectual property (203)
Interviews (816)
IPO (17935)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (86)
Layoffs (650)
Leadership (37)
Legal (10152)
Liver cancer (93)
Longevity (14)
Lung cancer (612)
Lymphoma (300)
Machine learning (33)
Management (66)
Manufacturing (687)
MASH (161)
Medical device (14938)
Medtech (14972)
Mergers & acquisitions (22826)
Metabolic disorders (1243)
Multiple sclerosis (145)
NASH (23)
Neurodegenerative disease (248)
Neuropsychiatric disorders (76)
Neuroscience (2826)
NextGen: Class of 2025 (7703)
Non-profit (5098)
Now hiring (60)
Obesity (594)
Opinion (318)
Ovarian cancer (148)
Pain (175)
Pancreatic cancer (187)
Parkinson's disease (251)
Partnered (32)
Patents (440)
Patient recruitment (356)
Peanut (58)
People (66447)
Pharmaceutical (145)
Pharmacy benefit managers (29)
Phase I (23467)
Phase II (33018)
Phase III (24885)
Pipeline (3382)
Policy (310)
Postmarket research (3554)
Preclinical (10604)
Press Release (72)
Prostate cancer (212)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (728)
Real estate (7428)
Recruiting (80)
Regulatory (28256)
Reports (65)
Research institute (2704)
Resumes & cover letters (651)
Rett syndrome (21)
RNA editing (16)
RSV (79)
Schizophrenia (144)
Series A (221)
Series B (166)
Service/supplier (30)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (171)
Sponsored (42)
Startups (4322)
State (2)
Stomach cancer (18)
Supply chain (105)
Tariffs (96)
The Weekly (113)
Vaccines (1075)
Venture capital (71)
Weight loss (415)
Women's health (67)
Worklife (21)
Date
Today (145)
Last 7 days (814)
Last 30 days (3962)
Last 365 days (33463)
2025 (30168)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1287)
Alabama (83)
Alaska (7)
Arizona (315)
Arkansas (14)
Asia (51141)
Australia (8994)
California (10328)
Canada (3022)
China (977)
Colorado (437)
Connecticut (465)
Delaware (298)
Europe (117627)
Florida (1505)
Georgia (334)
Hawaii (3)
Idaho (68)
Illinois (847)
India (57)
Indiana (499)
Iowa (20)
Japan (346)
Kansas (129)
Kentucky (40)
Louisiana (28)
Maine (81)
Maryland (1362)
Massachusetts (7690)
Michigan (330)
Minnesota (603)
Mississippi (6)
Missouri (129)
Montana (33)
Nebraska (26)
Nevada (111)
New Hampshire (81)
New Jersey (2834)
New Mexico (32)
New York (2761)
North Carolina (1484)
North Dakota (10)
Northern California (4807)
Ohio (315)
Oklahoma (22)
Oregon (51)
Pennsylvania (2119)
Puerto Rico (20)
Rhode Island (46)
South America (1655)
South Carolina (54)
South Dakota (1)
Southern California (3954)
Tennessee (157)
Texas (1611)
United States (37708)
Utah (309)
Virginia (262)
Washington D.C. (85)
Washington State (868)
West Virginia (4)
Wisconsin (106)
Wyoming (2)
There are 864,632 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Approvals
Arrowhead Secures Maiden Approval, First FDA Nod for Rare Genetic Metabolic Disorder
The FDA approval of the siRNA drug Redemplo caps off a tumultuous 12 months for Arrowhead, whose partnership with Sarepta caused its own stock to drop during the gene therapy maker’s safety troubles this summer.
November 18, 2025
·
2 min read
·
Heather McKenzie
Press Releases
Soundbites Announces U.S. Patent to Restore Hearing Sensitivity
November 18, 2025
·
1 min read
Press Releases
Lifordi Immunotherapeutics Secures Strategic Investment from Sanofi Ventures and Additional Capital from Existing Investors
November 18, 2025
·
1 min read
Press Releases
Hemostemix to Showcase Breakthrough Wound Healing Therapy at Innovations in Wound Care Conference Florida
November 18, 2025
·
1 min read
Press Releases
Next-Generation Cancer Diagnostics Market Size Worth USD 38.36 Billion by 2034
November 18, 2025
·
1 min read
Press Releases
Archeon Medical: first responder study shows novel ventilation device triples survival rates without brain damage in cardiac arrest care - US clinical trials to follow
November 18, 2025
·
1 min read
Press Releases
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer’s Disease Candidate INM-901
November 18, 2025
·
1 min read
Press Releases
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
November 18, 2025
·
1 min read
FDA
Makary Got His Man in Pazdur—But Can He Last as CDER Director?
A week into his tenure as head of the FDA’s Center for Drug Evaluation and Research, experts agree that Rick Pazdur is the “ideal fit” to stabilize the agency. And, according to one ex-FDA official, if his CBER counterpart Vinay Prasad tries to supersede Pazdur’s authority, “there will be hell to pay.”
November 18, 2025
·
6 min read
·
Heather McKenzie
Cardiovascular disease
Merck Extends Winrevair’s Win Streak With New Mid-Stage Data in Type of Hypertension
Winrevair yielded significant and meaningful clinical benefits for patients with combined post- and precapillary pulmonary hypertension, an indication that, according to BMO Capital Markets, has few treatment options.
November 18, 2025
·
2 min read
·
Tristan Manalac
1 of 86,464
Next
